| OCX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the OCX shares outstanding history going back to 11/6/2020:
Also see: OCX Market Cap History OCX YTD Return |
OCX Shares Outstanding History — OncoCyte Share Count Over Time
As of 5/5/2025 OncoCyte has 28.60 million OCX shares outstanding. Investors often track the OCX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows OCX share count trends over time, with 21 historical shares outstanding datapoints presented, dating back to 11/6/2020.
| OCX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||
OCX Historical Shares Outstanding: +61.03% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||
| OCX Stock Price Chart |
| About Insight Molecular Diagnostics Inc |
| Oncocyte Corporation is a precision diagnostics company. Co. is engaged in the development of Oncocytes tests and the acquisition of proprietary molecular technologies in the fields of oncology and transplantation. Co.'s products include DetermaIO, VitaGraft, DetermaCNI and GraftAssure. DetermaIO is a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. DetermaIO measures the expression level of 27 selected genes, which are interpreted through the use of a proprietary algorithm (patent pending) which computes a quantitative score (IO Score) that incorporates information from the immune inflammatory infiltrates within and around the tumor. We show 21 historical shares outstanding datapoints in our coverage of OCX's shares outstanding history. Understanding the changing numbers of OCX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like OCX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching OCX by allowing them to research OCX shares outstanding history as well as any other stock in our coverage universe. |
| OCX Current Stock Quote |
Quotes delayed 20 minutes  Free OCX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| OCX Share Performance |
| Shares Outstanding Peers |
| OncoCyte (OCX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ODT Shares Outstanding History ODYS Shares Outstanding History OFIX Shares Outstanding History OGN Shares Outstanding History OHRP Shares Outstanding History OKUR Shares Outstanding History OLMA Shares Outstanding History OM Shares Outstanding History OMED Shares Outstanding History OMER Shares Outstanding History More Healthcare companies » |
OCX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
